BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 34311438)

  • 21. Peripheral blood derived induced pluripotent stem cells (iPSCs) from a female with familial hypertrophic cardiomyopathy.
    Ross SB; Fraser ST; Bagnall RD; Semsarian C
    Stem Cell Res; 2017 Apr; 20():76-79. PubMed ID: 28395744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of two induced pluripotent stem cell (iPSC) lines from human breast milk using episomal reprogramming system.
    Tang C; Lu C; Ji X; Ma L; Zhou Q; Xiong M; Zhou W
    Stem Cell Res; 2019 Aug; 39():101511. PubMed ID: 31404746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation and characterization of two iPSC lines from human epicardium-derived cells.
    Paulitschek C; Schulze-Matz P; Hesse J; Schmidt T; Wruck W; Adjaye J; Schrader J
    Stem Cell Res; 2017 Apr; 20():50-53. PubMed ID: 28395740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Derivation of induced pluripotent stem cells from a familial Alzheimer's disease patient carrying the L282F mutation in presenilin 1.
    Poon A; Li T; Pires C; Nielsen TT; Nielsen JE; Holst B; Dinnyes A; Hyttel P; Freude KK
    Stem Cell Res; 2016 Nov; 17(3):470-473. PubMed ID: 27789396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluorescent tagged episomals for stoichiometric induced pluripotent stem cell reprogramming.
    Schmitt CE; Morales BM; Schmitz EMH; Hawkins JS; Lizama CO; Zape JP; Hsiao EC; Zovein AC
    Stem Cell Res Ther; 2017 Jun; 8(1):132. PubMed ID: 28583172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation of human induced pluripotent stem cell line FDCHDPi001-A from a Chinese Han Tourette's syndrome patient.
    Yuan A; Tao R; Yu S; Jing N; Sun J
    Stem Cell Res; 2021 Apr; 52():102227. PubMed ID: 33607468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reprogramming of dermal fibroblasts from a Duchenne muscular dystrophy patient carrying a deletion of exons 45-50 into an induced pluripotent stem cell line (CCMi005-A).
    Rovina D; Castiglioni E; Mallia S; Rabino M; Farini A; Belicchi M; Di Giuseppe G; Gervasini C; Torrente Y; Pompilio G; Gowran A
    Stem Cell Res; 2022 Oct; 64():102889. PubMed ID: 35961103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation of spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cell line SCA3.B11.
    Hansen SK; Borland H; Hasholt LF; Tümer Z; Nielsen JE; Rasmussen MA; Nielsen TT; Stummann TC; Fog K; Hyttel P
    Stem Cell Res; 2016 May; 16(3):589-92. PubMed ID: 27346191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation of induced pluripotent stem cell (iPSC) line from Charcot-Marie-Tooth disease patient with MPZ mutation (CMT1B).
    Son D; Kang PJ; Yun W; You S
    Stem Cell Res; 2017 Oct; 24():5-7. PubMed ID: 29034895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation of spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cell line SCA3.A11.
    Hansen SK; Borland H; Hasholt LF; Tümer Z; Nielsen JE; Rasmussen MA; Nielsen TT; Stummann TC; Fog K; Hyttel P
    Stem Cell Res; 2016 May; 16(3):553-6. PubMed ID: 27346190
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generation of an induced pluripotent stem cell line SDPHi002-A from a patient with lung cancer.
    Ai D; Yang X; Li X; Liu N; Xie X; Liu Y; Song W
    Stem Cell Res; 2023 Jun; 69():103096. PubMed ID: 37104933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation and characterization of human induced pluripotent stem cells lines from four patients diagnosed with schizophrenia and one healthy control.
    Stock R; Vogel S; Mau-Holzmann UA; Kriebel M; Wüst R; Fallgatter AJ; Volkmer H
    Stem Cell Res; 2020 Oct; 48():101961. PubMed ID: 32911325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation of a Crigler-Najjar Syndrome Type I patient-derived induced pluripotent stem cell line CNS705 (HHUUKDi005-A).
    Graffmann N; Martins S; Ljubikj T; Matte JC; Bohndorf M; Wruck W; Adjaye J
    Stem Cell Res; 2021 Mar; 51():102167. PubMed ID: 33485181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation and characterization of human-derived iPSC lines from one pair of dizygotic twins discordant for schizophrenia.
    Ni P; Wang H; Cai J; Ran J; Jiang Y; Zhao L; Wei J; Ni R; Wang Y; Ma X; Wang Q; Guo W; Li T
    Stem Cell Res; 2022 Apr; 60():102710. PubMed ID: 35182860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation of an induced pluripotent stem cell line SDQLCHi026-A from a hereditary tyrosinemia type I patient carrying compound heterozygote mutations in FAH gene.
    Zhang H; Liu C; Ma Y; Lin L; Lv Y; Gao M; Gai Z; Liu Y
    Stem Cell Res; 2021 May; 53():102331. PubMed ID: 33882394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human induced pluripotent stem cell line HMUi001-A derived from corneal stromal cells.
    Bikkuzin T; Shi Y; Sun B; Guo Y; Jin X; Han Z; Pavlov V; Zhang H
    Stem Cell Res; 2019 May; 37():101409. PubMed ID: 31121475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generation of an induced pluripotent stem cell line from a patient with retinitis pigmentosa caused by RP1 mutation.
    Zhang X; Moon SY; Zhang D; Chen SC; Lamey T; Thompson JA; McLaren T; De Roach JN; McLenachan S; Chen FK
    Stem Cell Res; 2019 May; 37():101452. PubMed ID: 31059986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Establishment of a Vietnamese ethnicity induced pluripotent stem cell line (VRISGi001-A) from umbilical cord blood hematopoietic stem cells under a feeder-free system.
    Tran TT; Nguyen TH; Nguyen TT; Nguyen XH
    Stem Cell Res; 2021 May; 53():102345. PubMed ID: 33878709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An achievement has been made in establishing an induced pluripotent stem cell line (SDPHi005-A) from a healthy Chinese male donor.
    Shao J; Jin Y; Shao C; Zhang X; Yang G
    Stem Cell Res; 2024 Jun; 77():103393. PubMed ID: 38531229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of induced pluripotent stem cell (iPSC) line from a 36-year-old Charcot-Marie-Tooth disease patient with GJB1 mutation (CMTX).
    Son D; Kang PJ; Yun W; You S
    Stem Cell Res; 2017 May; 21():9-12. PubMed ID: 28677541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.